Skip to main content

Advertisement

Log in

Need for clarification of results in the recent meta-analysis about SULT1A1 codon 213 polymorphism and breast cancer risk

  • Letter to the Editor
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Sun Y, Zang Z, Xu X, Zhang Z, Zhong L, Zan W, Zhao Y, Sun L (2010) The association of SULT1A1 codon 213 polymorphism and breast cancer susceptibility: meta-analysis from 16 studies involving 23,445 subjects. Breast Cancer Res Treat. doi:10.1007/s10549-010-0953-5

  2. The MARIE-GENICA Consortium (2010) Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women. Breast Cancer Res Treat 119:463–474

  3. Sillanpaa P, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, Vainio H, Mitrunen K, Hirvonen A (2005) Sulfotransferase 1A1 genotype as a potential modifier of breast cancer risk among premenopausal women. Pharmacogenet Genomics 15:749–752

    Article  PubMed  Google Scholar 

  4. Wang Z, Fu Y, Tang C, Lu S, Chu WM (2010) SULT1A1 R213H polymorphism and breast cancer risk: a meta-analysis based on 8, 454 cases and 11, 800 controls. Breast Cancer Res Treat 122:193–198

    Article  CAS  PubMed  Google Scholar 

  5. Economopoulos KP, Sergentanis TN (2010) Glutathione S-transferase P1 Ile105Val polymorphism and breast cancer risk: convergence and divergence of the two recent meta-analyses. Breast Cancer Res Treat. doi:10.1007/s10549-010-1143-1

  6. Economopoulos KP, Sergentanis TN (2010) Does race modify the association between CYP1B1 Val432Leu polymorphism and breast cancer risk? A critical appraisal of a recent meta-analysis. Breast Cancer Res Treat 124:293–294

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors are fully responsible for all the content and editorial decisions and have not received any financial support or other form of remuneration related to the development of this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pei-Hua Lu.

Additional information

Pei-Hua Lu and Mu-Xin Wei contributed equally to this work and should be considered as co-first authors.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lu, PH., Wei, MX., Li, C. et al. Need for clarification of results in the recent meta-analysis about SULT1A1 codon 213 polymorphism and breast cancer risk. Breast Cancer Res Treat 125, 599–600 (2011). https://doi.org/10.1007/s10549-010-1211-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-010-1211-6

Keywords

Navigation